OFFICIAL PUBLICATION OF

by its subsidiary APPco

Research Roundup

Debbie Rigby 02/02/2021

Debbie Rigby rounds up the latest in research news Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes A large systematic review and network meta-analysis of 764 randomised controlled trials has concluded that SGLT-2 inhibitors and GLP-1 receptor agonists reduced cardiovascular and renal outcomes in patients with type 2

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

Indeed. I encounter a disheartening amount of surprised pikachu faces when I explain that I'll need to examine the eye…

James Lawson

Teal questions pharmacist UTI programs

At this point with how much the AMA/RACGP banged on about the "one male that was treated" during the Queensland…

Vincent Chua

Union calls for ‘significant’ increase to Award

Hospital pharmacists should consider community pharmacy as an alternative.

Ernie Hanson

Union calls for ‘significant’ increase to Award

"“ workplaces are characterised by high stress, understaffing and unsustainable workloads and with an expanded scope of practice on the…

James Tsaoucis

Research Roundup

Previous The debate goes on

Next Time running out on APP2021 Super Early Bird savings

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous The debate goes on

Next Time running out on APP2021 Super Early Bird savings

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.